New-Generation Antibiotics for Treatment of Gram-Positive Infections: A Review with Focus on Endocarditis and Osteomyelitis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New-Generation Antibiotics for Treatment of Gram-Positive Infections: A Review with Focus on Endocarditis and Osteomyelitis
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 10, Issue 8, Pages 1743
Publisher
MDPI AG
Online
2021-04-19
DOI
10.3390/jcm10081743
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tedizolid as step-down therapy following daptomycin versus continuation of daptomycin against enterococci and Staphylococcus aureus (MRSA/VRSA) in a rat endocarditis model
- (2020) Kavindra V. Singh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of new antibiotics in the treatment of acute bacterial skin and skin-structure infections
- (2020) Matteo Bassetti et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Daptomycin plus Fosfomycin versus Daptomycin Alone for Methicillin-Resistant Staphylococcus aureus Bacteremia and Endocarditis. A Randomized Clinical Trial
- (2020) Miquel Pujol et al. CLINICAL INFECTIOUS DISEASES
- Assessment of in Vitro synergy of Daptomycin or Vancomycin plus Ceftaroline for Daptomycin non-susceptible Staphylococcus aureus
- (2020) Mary A. Hutton et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Treatment of osteoarticular, cardiovascular, intravascular-catheter-related and other complicated infections with dalbavancin and oritavancin: A systematic review
- (2020) Geren Thomas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source—a series of four cases
- (2020) Florian Hitzenbichler et al. INFECTION
- Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care
- (2020) Leama Ajaka et al. Antibiotics-Basel
- Omadacycline for Community-Acquired Bacterial Pneumonia
- (2019) Roman Stets et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ceftaroline Fosamil for the Treatment of Gram-Positive Endocarditis: CAPTURE Study Experience
- (2019) Christopher J. Destache et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Use of Ceftaroline Fosamil in Osteomyelitis: CAPTURE Study Experience
- (2019) Leonard B. Johnson et al. BMC INFECTIOUS DISEASES
- Clinical Data on Daptomycin Plus Ceftaroline Versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
- (2019) Matthew Geriak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and efficacy of prolonged use of dalbavancin in bone and joint infections
- (2019) L. Morata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Reappraisal of Linezolid Dosing in Renal Impairment to Improve Safety
- (2019) Ryan L. Crass et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Activities of New Antibiotics for the Treatment of Skin Infections
- (2019) Dee Shortridge et al. CLINICAL INFECTIOUS DISEASES
- Current Treatment Options for Acute Skin and Skin-structure Infections
- (2019) Yoav Golan CLINICAL INFECTIOUS DISEASES
- Real world use of Telavancin in the treatment of osteomyelitis
- (2019) Louis D. Saravolatz et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Multicenter clinical experience of real life Dalbavancin use in gram-positive infections
- (2019) S. Wunsch et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA and Europe (2014–17)
- (2019) Cecilia G Carvalhaes et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Daptomycin to bone and joint infections and prosthesis joint infections: a systematic review
- (2019) João Paulo Telles et al. Brazilian Journal of Infectious Diseases
- An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline Antibiotic
- (2019) Steven Opal et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Omadacycline
- (2019) Keith A Rodvold et al. CLINICAL INFECTIOUS DISEASES
- Microbiology and Preclinical Review of Omadacycline
- (2019) James A Karlowsky et al. CLINICAL INFECTIOUS DISEASES
- Off-label use of Ceftaroline Fosamil: a systematic review
- (2019) Arianna Pani et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Important new therapies for methicillin-resistant Staphylococcus aureus
- (2019) Matteo Bassetti et al. EXPERT OPINION ON PHARMACOTHERAPY
- Daptomycin-containing regimens for treatment of Gram-positive endocarditis
- (2019) Alessandro Russo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
- (2019) Carmen Hidalgo-Tenorio et al. Annals of Clinical Microbiology and Antimicrobials
- Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: an updated systematic review and meta-analysis
- (2019) Changcheng Shi et al. Journal of Global Antimicrobial Resistance
- The CHROME Study, a Real-world Experience of Single- and Multiple-Dose Oritavancin for Treatment of Gram-Positive Infections
- (2019) Mark Redell et al. Open Forum Infectious Diseases
- Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
- (2019) Erin K McCreary et al. Open Forum Infectious Diseases
- The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis
- (2018) Cristina García-de-la-Mària et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combination of Tedizolid and Daptomycin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations
- (2018) Jordan R. Smith et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna
- (2018) Selma Tobudic et al. CLINICAL INFECTIOUS DISEASES
- Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm
- (2018) Cristina El Haj et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Association of Higher Daptomycin Dose (7 mg/kg or Greater) with Improved Survival in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia
- (2018) Tristan T. Timbrook et al. PHARMACOTHERAPY
- Safety of Delafloxacin: Focus on Adverse Events of Special Interest
- (2018) Thomas Lodise et al. Open Forum Infectious Diseases
- Clinical Pharmacokinetics and Pharmacodynamics of Delafloxacin
- (2018) Jennifer Shiu et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Summary of the safety and tolerability of two treatment regimens of ceftaroline fosamil: 600 mg every 8 h versus 600 mg every 12 h
- (2018) Karen Cheng et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting
- (2018) Lélia Abad et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety
- (2018) Urania Rappo et al. Open Forum Infectious Diseases
- Outpatient treatment of osteomyelitis with telavancin
- (2017) Claudia P. Schroeder et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study
- (2017) Samia Arshad et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Delafloxacin Pharmacokinetics in Subjects With Varying Degrees of Renal Function
- (2017) Randall K. Hoover et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA)
- (2017) Iffat Shafiq et al. Infectious Diseases
- Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
- (2016) Kimberly C. Claeys et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Tedizolid in Methicillin-Resistant Staphylococcus aureus Experimental Foreign Body-Associated Osteomyelitis
- (2016) Kyung-Hwa Park et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
- (2016) Evan J. Zasowski et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Tedizolid in Methicillin-Resistant Staphylococcus epidermidis Experimental Foreign Body-Associated Osteomyelitis
- (2016) Kyung-Hwa Park et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients
- (2016) Nicholas S. Britt et al. CLINICAL INFECTIOUS DISEASES
- Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age
- (2016) Randall Hoover et al. CLINICAL THERAPEUTICS
- Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers
- (2016) Randall Hoover et al. CLINICAL THERAPEUTICS
- Should daptomycin–rifampin combinations for MSSA/MRSA isolates be avoided because of antagonism?
- (2016) C. Stein et al. INFECTION
- A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities
- (2016) Matthew Dryden et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer
- (2015) Anne-Marie Chaftari et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Efficacies of Tedizolid Phosphate, Vancomycin, and Daptomycin in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Endocarditis
- (2015) Liana C. Chan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 2015 ESC Guidelines for the management of infective endocarditis
- (2015) Gilbert Habib et al. EUROPEAN HEART JOURNAL
- Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry
- (2015) K. Malizos et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy
- (2015) Françoise Van Bambeke Future Microbiology
- Daptomycin combinations as alternative therapies in experimental foreign-body infection caused by meticillin-susceptible Staphylococcus aureus
- (2015) Cristina El Haj et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy and safety of high-dose daptomycin (>6mg/kg) for complicated bone and joint infections and implant-associated infections caused by Gram-positive bacteria
- (2015) Nancy Perrottet et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Telavancin for refractory methicillin-resistantStaphylococcus aureusbacteremia and infective endocarditis
- (2015) Michael A. Ruggero et al. Infectious Diseases
- Prolonged use of oritavancin for vancomycin-resistantEnterococcus faeciumprosthetic valve endocarditis
- (2015) Jennifer A. Johnson et al. Open Forum Infectious Diseases
- Platelet Profile in Patients with Acute Bacterial Skin and Skin Structure Infections Receiving Tedizolid or Linezolid: Findings from the Phase 3 ESTABLISH Clinical Trials
- (2014) Thomas P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Tedizolid in Subjects with Renal or Hepatic Impairment
- (2014) S. Flanagan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Large Retrospective Evaluation of the Effectiveness and Safety of Ceftaroline Fosamil Therapy
- (2014) A. M. Casapao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of the Antibiotic Activities of Daptomycin, Vancomycin, and the Investigational Fluoroquinolone Delafloxacin against Biofilms from Staphylococcus aureus Clinical Isolates
- (2014) Wafi Siala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study
- (2014) Martin E Stryjewski et al. BMC INFECTIOUS DISEASES
- Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline
- (2014) George Sakoulas et al. CLINICAL THERAPEUTICS
- The ATTAIN trials: efficacy and safety of telavancin compared with vancomycin for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia
- (2014) Steven L Barriere Future Microbiology
- Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations
- (2014) Joseph A. Paladino et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial
- (2014) Gregory J Moran et al. LANCET INFECTIOUS DISEASES
- The safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials
- (2014) S. Z. Wang et al. BMJ Open
- Ceftaroline in Combination With Trimethoprim-Sulfamethoxazole for Salvage Therapy of Methicillin-Resistant Staphylococcus aureus Bacteremia and Endocarditis
- (2014) Valeria Fabre et al. Open Forum Infectious Diseases
- Systematic Review and Meta-Analysis of Linezolid versus Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bacteremia
- (2013) Eleni P. Balli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Combined Pharmacodynamic Quantitative and Qualitative Model Reveals the Potent Activity of Daptomycin and Delafloxacin against Staphylococcus aureus Biofilms
- (2013) Julia Bauer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model
- (2013) Daniela Baldoni et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections
- (2013) Philippe Prokocimer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis
- (2013) R. Kullar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the Prodrug
- (2013) Shawn D. Flanagan et al. PHARMACOTHERAPY
- Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America
- (2012) D. R. Osmon et al. CLINICAL INFECTIOUS DISEASES
- Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia
- (2012) Hyun Jung Park et al. JOURNAL OF INFECTION
- Ceftaroline: a comprehensive update
- (2011) Darpan Kaushik et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antibiotic-Induced Biofilm Formation
- (2011) Jeffrey B. Kaplan INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
- Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure
- (2011) J. Joson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activities of High-Dose Daptomycin, Vancomycin, and Moxifloxacin Alone or in Combination with Clarithromycin or Rifampin in a Novel In Vitro Model of Staphylococcus aureus Biofilm
- (2010) J. Parra-Ruiz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Successful Treatment of Vancomycin-Intermediate Staphylococcus aureus Pacemaker Lead Infective Endocarditis with Telavancin
- (2010) L. A. Marcos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Usual and High Doses of Daptomycin in Combination with Rifampin versus Alternative Therapies in Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus
- (2010) C. Garrigos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contrasting Effects of Acidic pH on the Extracellular and Intracellular Activities of the Anti-Gram-Positive Fluoroquinolones Moxifloxacin and Delafloxacin againstStaphylococcus aureus
- (2010) Sandrine Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens
- (2010) E. Rubinstein et al. CLINICAL INFECTIOUS DISEASES
- Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin
- (2010) H. Nace et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus
- (2009) J. M. Miro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates
- (2009) F. F. Arhin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Salvage Treatment for Persistent Methicillin‐ResistantStaphylococcus aureusBacteremia: Efficacy of Linezolid With or Without Carbapenem
- (2009) Hee‐Chang Jang et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and tolerance of rifampicin–linezolid compared with rifampicin–cotrimoxazole combinations in prolonged oral therapy for bone and joint infections
- (2009) S. Nguyen et al. CLINICAL MICROBIOLOGY AND INFECTION
- Dalbavancin: a Novel Once-Weekly Lipoglycopeptide Antibiotic
- (2008) L. D. Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- Linezolid versus glycopeptide or β-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials
- (2007) Matthew E Falagas et al. LANCET INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now